Frontier Bio, founded with the mission to revolutionize regenerative medicine, focuses on engineering and manufacturing tissue for medical applications. Their vision is to create a future where lab-grown organs and tissues eliminate the need for animal testing, thus advancing medical research and treatment. The company specializes in developing engineered tissues for lungs, brains, and blood vessels, aiming to provide innovative solutions for clinical trials and biological development.
Notable affiliates include Veronica Salib, who has highlighted the impact of the FDA Modernization Act on the industry. Frontier Bio has garnered support from significant partnerships and has achieved key milestones in tissue engineering. Their work is paving the way for groundbreaking advancements in medical science, particularly in reducing reliance on animal testing and progressing toward viable lab-grown organs.
